567 related articles for article (PubMed ID: 7525628)
1. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL
Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
[TBL] [Abstract][Full Text] [Related]
5. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
[TBL] [Abstract][Full Text] [Related]
6. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
[TBL] [Abstract][Full Text] [Related]
7. Unresolved problems concerning optimal therapy of puberty in children with chronic renal diseases.
Hokken-Koelega AC; Saenger P; Cappa M; Greggio N;
J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():945-52. PubMed ID: 11529400
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.
de Boer H; Blok GJ; Popp-Snijders C; Stuurman L; Baxter RC; van der Veen E
J Clin Endocrinol Metab; 1996 Apr; 81(4):1371-7. PubMed ID: 8636336
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.
Hokken-Koelega A; Mulder P; De Jong R; Lilien M; Donckerwolcke R; Groothof J
Pediatr Nephrol; 2000 Jul; 14(7):701-6. PubMed ID: 10912546
[TBL] [Abstract][Full Text] [Related]
11. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.
Sas T; de Waal W; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666
[TBL] [Abstract][Full Text] [Related]
13. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
14. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
15. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
Sas T; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
[TBL] [Abstract][Full Text] [Related]
16. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
[TBL] [Abstract][Full Text] [Related]
17. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
18. High-dose growth hormone treatment of short children born small for gestational age.
de Zegher F; Maes M; Gargosky SE; Heinrichs C; Du Caju MV; Thiry G; De Schepper J; Craen M; Breysem L; Löfström A; Jönsson P; Bourguignon JP; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1996 May; 81(5):1887-92. PubMed ID: 8626853
[TBL] [Abstract][Full Text] [Related]
19. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
Lanes R; Jakubowicz S
J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
[TBL] [Abstract][Full Text] [Related]
20. Body proportions before and during growth hormone therapy in children with chronic renal failure.
de Graaff LC; Mulder PG; Hokken-Koelega AC
Pediatr Nephrol; 2003 Jul; 18(7):679-84. PubMed ID: 12734746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
